Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "Epidermolysis bullosa simplex"
Show Display Options
Rank Status Study
1 Not yet recruiting Diacerin for the Treatment of Epidermolysis Bullosa Simplex
Condition: Epidermolysis Bullosa Simplex
Intervention: Drug: Diacerin cream
2 Completed Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara
Condition: Epidermolysis Bullosa Simplex Dowling Meara
Intervention: Procedure: Taking of liquid and top of blisters
3 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
4 Unknown  Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
Condition: Epidermolysis Bullosa
Intervention: Drug: Oral erythromycin
5 Recruiting Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
Conditions: Epidermolysis Bullosa Simplex;   Epidermolysis Bullosa Simplex Kobner;   Weber-Cockayne Syndrome
Interventions: Drug: Sirolimus, 2%;   Drug: Vehicle
6 Recruiting Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Conditions: Epidermolysis Bullosa Simplex;   Pachyonychia Congenita
Interventions: Drug: Jojoba oil with broccoli sprout extract;   Drug: Jojoba oil (placebo)

Study has passed its completion date and status has not been verified in more than two years.